Send us Fan MailA synthethic replacement for ethanol that has all of the benefits but none of the drawbacks seems like science fiction but David Orren from GABA Labs thinks they have cracked the code.David is the MD and co-founder of GABA Labs, a potentially revolutionary start up that is aiming to produce a range of replacements for ethanol. These scientifically researched, but yet to be approved, ingredients could stimulate the same neuro-receptors in our brains as ethanol. According to David and his partner Prof. David Nutt, they could do it more accurately and they would be self limiting so over indulging would be impossible. But does the science stack up? How does it get FDA approval? And what sort of business model do you use when trying to disrupt one of humanities oldest industries?The fantastic Susan Boyle co-hosts this episode as Foxy is on a well deserved holiday.Support the showFor more high-lights and low-downs follow @BizBevPod on "X" or LinkedInBusiness of Beverages is self-funded and hosted/ edited/produced by Will Keating.Pádraig Fox co-hosts in a strictly personal capacity.All opinions are those of the person expressing them at all times. We're not sponsored but we would appreciate it if you could click the link above to support the show and help keep us ad free.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related